E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET

Francesco Ceci; Daniela E. Oprea-Lager; Louise Emmett; Judit A. Adam; Jamshed Bomanji; Johannes Czernin; Matthias Eiber; Uwe Haberkorn; Michael S. Hofman; Thomas A. Hope; Rakesh Kumar; Steven P. Rowe; Sarah M. Schwarzenboeck; Stefano Fanti; Ken Herrmann

doi:https://doi.org/10.1007/s00259-021-05245-y

E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET

Francesco Ceci, Daniela E. Oprea-Lager, Louise Emmett, Judit A. Adam, Jamshed Bomanji, Johannes Czernin, Matthias Eiber, Uwe Haberkorn, Michael S. Hofman, Thomas A. Hope, Rakesh Kumar, Steven P. Rowe, Sarah M. Schwarzenboeck, Stefano Fanti, Ken Herrmann

Research output: Contribution to journal › Article › Academic › peer-review

176 Citations (Scopus)

Abstract

Rationale: The development of consensus guidelines for interpretation of Prostate-Specific Membrane Antigen (PSMA)-Positron Emission Tomography (PET) is needed to provide more consistent reports in clinical practice. The standardization of PSMA-PET interpretation may also contribute to increasing the data reproducibility within clinical trials. Finally, guidelines in PSMA-PET interpretation are needed to communicate the exact location of findings to referring physicians, to support clinician therapeutic management decisions. Methods: A panel of worldwide experts in PSMA-PET was established. Panelists were selected based on their expertise and publication record in the diagnosis or treatment of PCa, in their involvement in clinical guidelines and according to their expertise in the clinical application of radiolabeled PSMA inhibitors. Panelists were actively involved in all stages of a modified, nonanonymous, Delphi consensus process. Results: According to the findings obtained by modified Delphi consensus process, panelist recommendations were implemented in a structured report for PSMA-PET. Conclusions: The E-PSMA standardized reporting guidelines, a document supported by the European Association of Nuclear Medicine (EANM), provide consensus statements among a panel of experts in PSMA-PET imaging, to develop a structured report for PSMA-PET in prostate cancer and to harmonize diagnostic interpretation criteria.

Original language	English
Pages (from-to)	1626-1638
Number of pages	13
Journal	European journal of nuclear medicine and molecular imaging
Volume	48
Issue number	5
Early online date	2021
DOIs	https://doi.org/10.1007/s00259-021-05245-y
Publication status	Published - May 2021

Keywords

Consensus panel
EANM guidelines
PSMA prostate cancer
PSMA-PET
Prostate cancer guidelines
Structured report

Access to Document

https://doi.org/10.1007/s00259-021-05245-y

Cite this

Ceci, F., Oprea-Lager, D. E., Emmett, L., Adam, J. A., Bomanji, J., Czernin, J., Eiber, M., Haberkorn, U., Hofman, M. S., Hope, T. A., Kumar, R., Rowe, S. P., Schwarzenboeck, S. M., Fanti, S., & Herrmann, K. (2021). E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET. European journal of nuclear medicine and molecular imaging, 48(5), 1626-1638. https://doi.org/10.1007/s00259-021-05245-y

@article{088f1c3b2b254828b24800a5622d9c1d,

title = "E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET",

abstract = "Rationale: The development of consensus guidelines for interpretation of Prostate-Specific Membrane Antigen (PSMA)-Positron Emission Tomography (PET) is needed to provide more consistent reports in clinical practice. The standardization of PSMA-PET interpretation may also contribute to increasing the data reproducibility within clinical trials. Finally, guidelines in PSMA-PET interpretation are needed to communicate the exact location of findings to referring physicians, to support clinician therapeutic management decisions. Methods: A panel of worldwide experts in PSMA-PET was established. Panelists were selected based on their expertise and publication record in the diagnosis or treatment of PCa, in their involvement in clinical guidelines and according to their expertise in the clinical application of radiolabeled PSMA inhibitors. Panelists were actively involved in all stages of a modified, nonanonymous, Delphi consensus process. Results: According to the findings obtained by modified Delphi consensus process, panelist recommendations were implemented in a structured report for PSMA-PET. Conclusions: The E-PSMA standardized reporting guidelines, a document supported by the European Association of Nuclear Medicine (EANM), provide consensus statements among a panel of experts in PSMA-PET imaging, to develop a structured report for PSMA-PET in prostate cancer and to harmonize diagnostic interpretation criteria.",

keywords = "Consensus panel, EANM guidelines, PSMA prostate cancer, PSMA-PET, Prostate cancer guidelines, Structured report",

author = "Francesco Ceci and Oprea-Lager, {Daniela E.} and Louise Emmett and Adam, {Judit A.} and Jamshed Bomanji and Johannes Czernin and Matthias Eiber and Uwe Haberkorn and Hofman, {Michael S.} and Hope, {Thomas A.} and Rakesh Kumar and Rowe, {Steven P.} and Schwarzenboeck, {Sarah M.} and Stefano Fanti and Ken Herrmann",

note = "Funding Information: The authors would like to thank the European Association of Nuclear Medicine (EANM) and the EANM Oncological and Theranostic Committee for supporting this project. Publisher Copyright: {\textcopyright} 2021, The Author(s). Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = may,

doi = "https://doi.org/10.1007/s00259-021-05245-y",

language = "English",

volume = "48",

pages = "1626--1638",

journal = "European journal of nuclear medicine and molecular imaging",

issn = "1619-7070",

publisher = "Springer Verlag",

number = "5",

}

Ceci, F, Oprea-Lager, DE, Emmett, L, Adam, JA, Bomanji, J, Czernin, J, Eiber, M, Haberkorn, U, Hofman, MS, Hope, TA, Kumar, R, Rowe, SP, Schwarzenboeck, SM, Fanti, S & Herrmann, K 2021, 'E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET', European journal of nuclear medicine and molecular imaging, vol. 48, no. 5, pp. 1626-1638. https://doi.org/10.1007/s00259-021-05245-y

TY - JOUR

T1 - E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET

AU - Ceci, Francesco

AU - Oprea-Lager, Daniela E.

AU - Emmett, Louise

AU - Adam, Judit A.

AU - Bomanji, Jamshed

AU - Czernin, Johannes

AU - Eiber, Matthias

AU - Haberkorn, Uwe

AU - Hofman, Michael S.

AU - Hope, Thomas A.

AU - Kumar, Rakesh

AU - Rowe, Steven P.

AU - Schwarzenboeck, Sarah M.

AU - Fanti, Stefano

AU - Herrmann, Ken

N1 - Funding Information: The authors would like to thank the European Association of Nuclear Medicine (EANM) and the EANM Oncological and Theranostic Committee for supporting this project. Publisher Copyright: © 2021, The Author(s). Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/5

Y1 - 2021/5

N2 - Rationale: The development of consensus guidelines for interpretation of Prostate-Specific Membrane Antigen (PSMA)-Positron Emission Tomography (PET) is needed to provide more consistent reports in clinical practice. The standardization of PSMA-PET interpretation may also contribute to increasing the data reproducibility within clinical trials. Finally, guidelines in PSMA-PET interpretation are needed to communicate the exact location of findings to referring physicians, to support clinician therapeutic management decisions. Methods: A panel of worldwide experts in PSMA-PET was established. Panelists were selected based on their expertise and publication record in the diagnosis or treatment of PCa, in their involvement in clinical guidelines and according to their expertise in the clinical application of radiolabeled PSMA inhibitors. Panelists were actively involved in all stages of a modified, nonanonymous, Delphi consensus process. Results: According to the findings obtained by modified Delphi consensus process, panelist recommendations were implemented in a structured report for PSMA-PET. Conclusions: The E-PSMA standardized reporting guidelines, a document supported by the European Association of Nuclear Medicine (EANM), provide consensus statements among a panel of experts in PSMA-PET imaging, to develop a structured report for PSMA-PET in prostate cancer and to harmonize diagnostic interpretation criteria.

AB - Rationale: The development of consensus guidelines for interpretation of Prostate-Specific Membrane Antigen (PSMA)-Positron Emission Tomography (PET) is needed to provide more consistent reports in clinical practice. The standardization of PSMA-PET interpretation may also contribute to increasing the data reproducibility within clinical trials. Finally, guidelines in PSMA-PET interpretation are needed to communicate the exact location of findings to referring physicians, to support clinician therapeutic management decisions. Methods: A panel of worldwide experts in PSMA-PET was established. Panelists were selected based on their expertise and publication record in the diagnosis or treatment of PCa, in their involvement in clinical guidelines and according to their expertise in the clinical application of radiolabeled PSMA inhibitors. Panelists were actively involved in all stages of a modified, nonanonymous, Delphi consensus process. Results: According to the findings obtained by modified Delphi consensus process, panelist recommendations were implemented in a structured report for PSMA-PET. Conclusions: The E-PSMA standardized reporting guidelines, a document supported by the European Association of Nuclear Medicine (EANM), provide consensus statements among a panel of experts in PSMA-PET imaging, to develop a structured report for PSMA-PET in prostate cancer and to harmonize diagnostic interpretation criteria.

KW - Consensus panel

KW - EANM guidelines

KW - PSMA prostate cancer

KW - PSMA-PET

KW - Prostate cancer guidelines

KW - Structured report

UR - http://www.scopus.com/inward/record.url?scp=85101080430&partnerID=8YFLogxK

U2 - https://doi.org/10.1007/s00259-021-05245-y

DO - https://doi.org/10.1007/s00259-021-05245-y

M3 - Article

C2 - 33604691

SN - 1619-7070

VL - 48

SP - 1626

EP - 1638

JO - European journal of nuclear medicine and molecular imaging

JF - European journal of nuclear medicine and molecular imaging

IS - 5

ER -

E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET

Abstract

Keywords

Access to Document

Other files and links

Cite this